|
BIMO Inspections Down 19 Percent From 2010, Most Sponsors Passing
The FDA conducted 949 bioresearch monitoring inspections in fiscal 2011 — 220 fewer inspections than the year prior — with the decrease spread among all relevant agency centers as they move to a more risk-based approach.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Related Articles
Hamburg: Conditions Observed During Compounding Pharmacy Inspections Were "Startling"Hamburg: Conditions Observed During Compounding Pharmacy Inspections Were "Startling"Hamburg: Resource Constraints Limit Compounding Inspection PushKeystone Gets Warning After FDA Finds Wooden Sticks Used in Drug Manufacture
|
Subscribe
Archives